Latest Delisting News

Red Hawk Mining has issued a supplementary target's statement endorsing FMG’s increased $1.20 per share takeover offer, with FMG now holding a commanding 78% stake. The directors urge shareholders to accept the offer ahead of the March 3 closing date, citing the absence of superior proposals.

Fortescue Ltd has increased its takeover offer for Red Hawk Mining to $1.20 per share after securing acceptance from major shareholders, pushing its stake to approximately 78%. This move triggers the offer’s increased price condition and sets the stage for Red Hawk’s likely delisting from the ASX.

Vmoto reports a 33% decline in FY24 unit sales but maintains operational cash flow positivity and secures new joint ventures in Thailand and Mexico to bolster its electric mobility footprint.

Mako Gold Limited’s securities have been suspended from ASX trading following Aurum Resources’ dispatch of compulsory acquisition notices, signaling a pivotal ownership transition.

Redivium Limited remains suspended from ASX trading following a failed entitlement offer and key director resignations, raising fresh doubts about its financial viability and governance.

Medlab Clinical reports a near-empty cash balance and zero receipts in Q2 2025, while actively pursuing a business acquisition ahead of its ASX removal date.

Astral Resources NL has initiated an off-market takeover offer for Maximus Resources Limited, proposing one Astral share for every two Maximus shares. The Maximus Board unanimously recommends acceptance, highlighting a significant premium and strategic consolidation benefits.

Argent BioPharma reports strategic cost-cutting moves including facility closures and delisting from the LSE, while securing German distribution approval and raising significant capital to support its drug pipeline.

Jervois Global Limited has entered a pivotal recapitalization agreement with Millstreet Capital Management, involving a US$145 million equity injection and a pre-packaged Chapter 11 bankruptcy process. The company aims to strengthen its balance sheet and continue operations uninterrupted while preparing for a strategic restart of its nickel-cobalt refinery in Brazil.

Visioneering Technologies reported a mixed Q4 FY'24 with a slight revenue decline but stronger cash flow and expanding global footprint, underpinned by promising clinical trial data.

Golden Horse Minerals has successfully listed on the ASX, raising A$18 million to fund exploration across a consolidated 130km strike in Western Australia's Southern Cross Greenstone Belt. The company is gearing up for a major drilling campaign at the historic Hopes Hill gold mine.

Little Green Pharma reports a robust 75% revenue increase to $9.5 million for December quarter, driven by strong European market growth and strategic product launches.